Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:21 2024-04-19 am EDT 5-day change 1st Jan Change
92.75 GBX -1.85% Intraday chart for Oxford Nanopore Technologies plc -14.83% -55.45%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises AN
Kepler Cheuvreux likes Diageo; BofA lifts Man AN
IP Group net asset value declines amid supply chain issues, inflation AN
Transcript : Oxford Nanopore Technologies plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 09:00 AM
Oxford Nanopore Technologies Launches PromethION 2 Integrated into Open Early Access CI
Good signals from central banks Our Logo
Oxford Nanopore Technologies top team buys shares AN
ANALYST RECOMMENDATIONS : AMD, Micron Technology, Snowflake, Zoom, Okta... Our Logo
ITV, LondonMetric, Man, Domino's get upgrades AN
What’s happening to the US economy? Our Logo
Oxford Nanopore confident in future opportunities despite weak 2023 AN
ANALYST RECOMMENDATIONS : Crowdstrike, Target, Antofagasta, Direct Line Insurance, Premier Foods... Our Logo
Shares rise in London ahead of budget Our Logo
Oxford Nanopore Technologies' FY23 Loss Widens; Revenue Falls MT
Transcript : Oxford Nanopore Technologies plc, Q4 2023 Earnings Call, Mar 06, 2024
ConvaTec profit doubles; DS smith trades in line AN
Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES Reports FY23 Revenue GBP169.7M MT
Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES Reports FY23 Loss GBX-19.00 MT
Oxford Nanopore Technologies plc Provides Earnings Guidance for the Year 2024 CI
Oxford Nanopore Technologies plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EXECUTIVE CHANGES: Metro Bank names new CFO; Corre exec leaves AN
Oxford Nanopore Technologies plc Announces Directorate Change CI
The calm after the storm Our Logo
ANALYST RECOMMENDATIONS : Amex, Apollo Global Management, Crowdstrike, Workday, Abrdn... Our Logo
IP Group expects net assets to fall in 2023 trading update AN
Chart Oxford Nanopore Technologies plc
More charts
Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Company’s segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
0.9275 GBP
Average target price
2.13 GBP
Spread / Average Target
+129.65%
Consensus
  1. Stock Market
  2. Equities
  3. ONT Stock
  4. News Oxford Nanopore Technologies plc
  5. Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES Reports FY21 EPS GBX23.00